¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14
±³À°ÀÏÀÚ : 2022-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium 
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : kaslsecretariat@hbni.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø / ºñȸ¿ø, ¿Â¶óÀΠȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:10~10:35 Conventional and New Biomarkers for the Management of Chronic Hepatitis B Virus Infection  Marc G. Ghany(National Institute of Health, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 10:35~11:00 Clinical Features of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Chronic Liver Disease  Ju Dong Yang(Cedars-Sinai Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:00~11:25 Novel Biomarkers for Renal Outcomes in Patients with Liver Cirrhosis  Jasmohan S. Bajaj(Virginia Commonwealth Univ., USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:25~11:50 Glycemic Control and Non-Alcoholic Fatty Liver Disease Prognosis  Manal F. Abdelmalek(Duke Univ. Medical Center, USA) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:20 Epidemiology and Natural History of Autoimmune Liver Diseases  Á¤¼÷Çâ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:20~13:40 Pathogenesis of Autoimmune Liver Diseases: Genetics and Environmental Factors  Áø¿µÁÖ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:40~14:00 Autoimmune Liver Diseases after Viral Infections Including COVID-19 and Vaccines  ±è°æ¾Æ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:20 How Do Drugs Trigger Autoimmune Liver Injury?: Immune Checkpoint Inhibitors and Biological Agents  À¯¼öÁ¾(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Diagnosis of Autoimmune Hepatitis and Overlap Syndrome  ¹ÚÁ¤±æ(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Differential Pathologic Features between AIH, PBC and PSC  ÀÌÇý¿ø(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 Standard and Emerging Treatments of Autoimmune Liver Disease  ¹Ú¼ö¿µ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Rescue Therapies for Relapsing and Difficult-To-Treat Autoimmune Liver Disease  ¼ÛÁ¤Àº(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:30~13:00 ÃÊÀ½ÆÄ ±â±â ¼¼Æà ¹æ¹ý  ±èż®(°­¿øÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:00~13:30 Á¤»ó °£ÃÊÀ½ÆÄ ½ºÄµ  ¼ºÇʼö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~14:00 Á¤»ó Ãé´ãµµ ÃÊÀ½ÆÄ ½ºÄµ  °­¹Î±Ô(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:00~14:30 °£Áúȯ ¹× Á¾±« ÃÊÀ½ÆÄ ½ºÄµ  ÀÌÀ¯¸²(°æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ)Á¦35ȸ Ãá°è Single Topic Symposium : 2022-05-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-15
´ÙÀ½±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ KSIN Spring symposium & Basic Training Course 2022 : 2022-05-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 26 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 23 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 15 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 13 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 24 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 9 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 13 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 14 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 19 2024-05-10
20655 ¼­¿ï Á¦ 66ȸ Çѱ¹Ç×°ø¿ìÁÖÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-24 0 7 2024-05-10
20654 ´ëÀü °ø°ø±â°ü ÀçÁ÷ÀÇ»ç Ãá°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-05-24 0 11 2024-05-10
20653 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-24 0 14 2024-05-10
20652 ¼­¿ï Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦ 44 Â÷ KSTH Ãá°èÇмú´ëȸ : 2024-05-24 0 13 2024-05-10
20651 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 18 2024-05-10
20650 °æ±â Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­ÁÂ(¸¸¼º±âħ, ºÒ¸éÁõ) : 2024-05-23 0 6 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷